Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. 1979

S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch

A double-blind, placebo-controlled trial of interferon prophylaxis against viral infections was conducted in renal-transplant recipients receiving standard immunosuprressive therapy with or without antithymocyte globulin. Interferon was administered for six weeks, beginning on the day of transplantation. Cytomegalovirus excretion began earlier and viremia was more frequent in placebo-treated than in interferon-treated patients. Cytomegalovirus viremia correlated with clinical syndromes was more frequent in recipients of antithymocyte globulin. In contrast, neither interferon nor antithymocyte globulin altered excretion of herpes simplex virus. Reversible leukopenia and thrombocytopenia occurred in seven interferon recipients. Patient and graft survival were comparable in interferon and placebo groups. There preliminary results suggest that a six-week course of prophylactic interferon delays shedding of cytomegalovirus and decreases the incidence of viremia after transplantation. In contrast, antithymocyte globulin appears to increase the severity of infection from cytomegalovirus among these patients.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
July 1984, Archives of surgery (Chicago, Ill. : 1960),
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
February 1988, Transplantation proceedings,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
January 1985, The Journal of trauma,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
June 1980, Infection and immunity,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
May 1981, Antimicrobial agents and chemotherapy,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
May 1986, Current eye research,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
January 1974, Advances in neurology,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
January 1987, Postepy higieny i medycyny doswiadczalnej,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
July 2011, PLoS pathogens,
S H Cheeseman, and R H Rubin, and J A Stewart, and N E Tolkoff-Rubin, and A B Cosimi, and K Cantell, and J Gilbert, and S Winkle, and J T Herrin, and P H Black, and P S Russell, and M S Hirsch
December 1997, Cancer letters,
Copied contents to your clipboard!